Introduction to the Study
Researchers at The University of Manchester have uncovered a potential method to predict cognitive impairment following a stroke by monitoring changes in a protein associated with inflammation, known as interleukin-6 (IL-6). This discovery could be crucial in identifying individuals at risk of developing memory and thinking problems after experiencing a stroke. The study also highlights the role of smoking in exacerbating these cognitive issues due to persistent inflammation.
Details of the Research
Published in the journal Alzheimer’s & Dementia, this research is part of the Stroke IMPaCT study, which involves a network of European and North American researchers. The study aims to understand how inflammation and immune responses contribute to cognitive decline after a stroke. The research team followed patients treated for ischemic stroke at Salford Royal Hospital, part of the Northern Care Alliance NHS Foundation Trust.
Methodology and Findings
The researchers measured IL-6 levels in patients shortly after their stroke and then again at intervals of 6–9 months and 18–21 months. Participants also underwent comprehensive tests to assess their memory and cognitive abilities. The findings revealed that IL-6 levels typically spiked soon after a stroke but returned to normal within 6–9 months for most patients. However, in some individuals, IL-6 levels remained elevated or increased again, making them approximately eight times more likely to experience cognitive difficulties.
Impact of Smoking on Inflammation
The study also identified significant differences between smokers and non-smokers. Smokers exhibited a distinct pattern of IL-6 changes post-stroke, indicating prolonged inflammation. This ongoing inflammation was more strongly associated with cognitive and memory problems, suggesting that smoking may hinder the body’s ability to recover from inflammation after a stroke.
Expert Insights
Natasha Carmichael, an MBPhD researcher at The University of Manchester and lead author of the study, emphasized the importance of tracking inflammation over time. “Inflammation after stroke doesn’t just happen once and disappear. By tracking this protein over time, we may be able to identify patients at greater risk of cognitive problems and eventually tailor support or treatments to them,” she stated.
Professor Craig Smith, a Professor of Stroke Medicine at The University of Manchester and Consultant at Salford Royal, added, “Our findings suggest it’s not just the initial spike in inflammation that matters—it’s whether it properly settles down after the stroke. Smoking appears to interfere with this recovery, leaving people more vulnerable to memory and thinking problems.”
Future Implications
Professor Stuart Allan noted that if future studies confirm IL-6 as a causative factor, medications that block this protein could potentially be used to protect brain health. Co-lead author Harry Deijnen from the University of Manchester remarked, “Though it is clear that more research is needed, these results point towards new opportunities to improve long-term brain health by focusing on the body’s inflammatory recovery after stroke.”
Conclusion
This study underscores the importance of monitoring inflammation markers like IL-6 in stroke patients to predict and potentially mitigate cognitive decline. The findings also highlight the detrimental impact of smoking on post-stroke recovery, emphasizing the need for targeted interventions to support brain health in these individuals.
🔗 **Fuente:** https://medicalxpress.com/news/2026-03-inflammation-protein-cognitive-impairment.html